HRP20170880T1 - Sastavi za brtvljenje - Google Patents
Sastavi za brtvljenje Download PDFInfo
- Publication number
- HRP20170880T1 HRP20170880T1 HRP20170880TT HRP20170880T HRP20170880T1 HR P20170880 T1 HRP20170880 T1 HR P20170880T1 HR P20170880T T HRP20170880T T HR P20170880TT HR P20170880 T HRP20170880 T HR P20170880T HR P20170880 T1 HRP20170880 T1 HR P20170880T1
- Authority
- HR
- Croatia
- Prior art keywords
- combination according
- combination
- tissue factor
- protein
- fibrinogen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/06—Use of macromolecular materials
- A61L33/12—Polypeptides, proteins or derivatives thereof, e.g. degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/043—Mixtures of macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/10—Polypeptides; Proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/10—Polypeptides; Proteins
- A61L24/106—Fibrin; Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/06—Use of macromolecular materials
- A61L33/12—Polypeptides, proteins or derivatives thereof, e.g. degradation products thereof
- A61L33/126—Fibrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Sealing Material Composition (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Claims (15)
1. Kombinacija koja sadrži lipidirani tkivni faktor, trombin i fibrinogen.
2. Kombinacija u skladu s patentnim zahtjevom 1, pri čemu najmanje jedno N-glikozilacijsko mjesto tkivnog faktora nije funkcionalno.
3. Kombinacija u skladu s bilo kojim od patentnih zahtjeva 1-2, pri čemu je navedeni tkivni faktor fuzijski protein koji sadrži prvi dio koji sadrži protein tkivnog faktora i drugi dio koji sadrži drugi peptid ili protein.
4. Kombinacija u skladu s patentnim zahtjevom 3, pri čemu je drugi dio oznaka.
5. Kombinacija u skladu s bilo kojim od patentnih zahtjeva 1-4, pri čemu fuzijski protein ima prvi dio koji sadrži zreli protein ljudskog tkivnog faktora s najmanje jednim od N-glikozilacijskih mjesta koje je nefunkcionalno i drugi dio koji sadrži His-oznaku.
6. Kombinacija u skladu s patentnim zahtjevom 5, pri čemu fuzijski protein odgovara SEQ ID NO:5.
7. Kombinacija u skladu s patentnim zahtjevom 6, pri čemu je lipidirani TF umetnut u mikrovezikulu.
8. Kombinacija u skladu s bilo kojim od patentnih zahtjeva 1-14, pri čemu je trombin ljudski trombin.
9. Kombinacija u skladu s bilo kojim od patentnih zahtjeva 1-15, pri čemu je fibrinogen ljudski fibrinogen.
10. Sastav za brtvljenje sadrži kombinaciju u skladu s bilo kojim od patentnih zahtjeva 1-9, i nosač materijala.
11. Farmaceutski sastav sadrži terapijski učinkovitu količinu kombinacije kako je definirana u bilo kojem od patentnih zahtjeva 1-9, zajedno s drugim odgovarajućim farmaceutski ili veterinarski prihvatljivim ekscipijensima i/ili nosačima.
12. Kombinacija u skladu s bilo kojim od patentnih zahtjeva 1-9 ili sastav u skladu s patentnim zahtjevom 10 za uporabu kao agens za brtvljenje.
13. Kombinacija u skladu s bilo kojim od patentnih zahtjeva 1-9 ili sastav u skladu s patentnim zahtjevom 10-11 za uporabu kao lijek.
14. Kombinacija u skladu s bilo kojim od patentnih zahtjeva 1-9 ili sastav u skladu s bilo kojim od patentnih zahtjeva 10-11 za uporabu u liječenju krvarenja.
15. Komplet sadrži kombinaciju definiranu u bilo kojem od patentnih zahtjeva 1-9 i aplikator koji omogućuje istovremenu primjenu svih sastavnica koje čine kombinaciju.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12198839.8A EP2745852A1 (en) | 2012-12-21 | 2012-12-21 | Sealant compositions |
| EP13821692.4A EP2934612B1 (en) | 2012-12-21 | 2013-12-20 | Sealant compositions |
| PCT/EP2013/077674 WO2014096354A1 (en) | 2012-12-21 | 2013-12-20 | Sealant compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20170880T1 true HRP20170880T1 (hr) | 2017-08-25 |
Family
ID=47563088
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20170880TT HRP20170880T1 (hr) | 2012-12-21 | 2013-12-20 | Sastavi za brtvljenje |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20160082145A1 (hr) |
| EP (2) | EP2745852A1 (hr) |
| JP (1) | JP6518591B2 (hr) |
| CN (1) | CN104955493A (hr) |
| AU (1) | AU2013366544B2 (hr) |
| BR (1) | BR112015014926B1 (hr) |
| CY (1) | CY1118938T1 (hr) |
| DK (1) | DK2934612T3 (hr) |
| ES (1) | ES2627053T3 (hr) |
| HR (1) | HRP20170880T1 (hr) |
| HU (1) | HUE034649T2 (hr) |
| LT (1) | LT2934612T (hr) |
| MX (1) | MX361222B (hr) |
| PL (1) | PL2934612T3 (hr) |
| PT (1) | PT2934612T (hr) |
| SI (1) | SI2934612T1 (hr) |
| WO (1) | WO2014096354A1 (hr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109010906B (zh) * | 2018-08-16 | 2021-05-14 | 陈明远 | 一种促进术后伤口局部止血及促进术后创面上皮化的生物胶水及其工作方法 |
| US11666682B2 (en) * | 2020-08-31 | 2023-06-06 | Ethicon, Inc. | Method of stopping CSF leaks and apparatus therefor |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE241340T1 (de) * | 1994-02-17 | 2003-06-15 | New York Blood Ct Inc | Biologische bioadhäsive präparate, die fibrinkleber und liposomen enthalten, verfahren für ihre herstellung und verwendung |
| JP2002514948A (ja) * | 1996-02-20 | 2002-05-21 | コーヒージョン・コーポレーション | 組織シーラント組成物とその使用方法 |
| WO1999018931A1 (en) * | 1997-10-10 | 1999-04-22 | University Of Virginia | Use of fibrin sealant to maintain hemostasis, lymphostasis and prevent local accumulation of body fluids |
| EP1749536A1 (en) * | 2005-08-03 | 2007-02-07 | Thrombotargets Europe, S.L. | Activated factor X stimulants as new antihemorrhagic agents for topical use |
| EP1939218A1 (en) * | 2006-12-29 | 2008-07-02 | Thrombotargets Europe, S.L. | Microvesicles derived from recombinant yeast having haemostatic activities and uses thereof |
| EP2145695A1 (de) | 2008-07-14 | 2010-01-20 | Sika Technology AG | Vorrichtung zur Klebstoffapplikation |
| EP2380905A1 (en) | 2010-04-19 | 2011-10-26 | Thrombotargets Europe, S.L. | Phospholipid-enriched vesicles bearing tissue factor having haemostatic activities and uses thereof |
-
2012
- 2012-12-21 EP EP12198839.8A patent/EP2745852A1/en not_active Withdrawn
-
2013
- 2013-12-20 SI SI201330670T patent/SI2934612T1/sl unknown
- 2013-12-20 MX MX2015007625A patent/MX361222B/es active IP Right Grant
- 2013-12-20 AU AU2013366544A patent/AU2013366544B2/en not_active Ceased
- 2013-12-20 HR HRP20170880TT patent/HRP20170880T1/hr unknown
- 2013-12-20 PL PL13821692T patent/PL2934612T3/pl unknown
- 2013-12-20 US US14/653,862 patent/US20160082145A1/en not_active Abandoned
- 2013-12-20 HU HUE13821692A patent/HUE034649T2/hu unknown
- 2013-12-20 PT PT138216924T patent/PT2934612T/pt unknown
- 2013-12-20 ES ES13821692.4T patent/ES2627053T3/es active Active
- 2013-12-20 WO PCT/EP2013/077674 patent/WO2014096354A1/en active Application Filing
- 2013-12-20 BR BR112015014926A patent/BR112015014926B1/pt not_active IP Right Cessation
- 2013-12-20 EP EP13821692.4A patent/EP2934612B1/en active Active
- 2013-12-20 DK DK13821692.4T patent/DK2934612T3/en active
- 2013-12-20 CN CN201380071345.XA patent/CN104955493A/zh active Pending
- 2013-12-20 LT LTEP13821692.4T patent/LT2934612T/lt unknown
- 2013-12-20 JP JP2015548630A patent/JP6518591B2/ja not_active Expired - Fee Related
-
2017
- 2017-06-08 CY CY20171100597T patent/CY1118938T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1118938T1 (el) | 2018-01-10 |
| MX361222B (es) | 2018-11-30 |
| PL2934612T3 (pl) | 2017-08-31 |
| HUE034649T2 (hu) | 2018-02-28 |
| SI2934612T1 (sl) | 2017-08-31 |
| LT2934612T (lt) | 2017-07-25 |
| AU2013366544B2 (en) | 2017-05-25 |
| EP2934612A1 (en) | 2015-10-28 |
| DK2934612T3 (en) | 2017-06-26 |
| EP2934612B1 (en) | 2017-03-15 |
| MX2015007625A (es) | 2015-12-15 |
| PT2934612T (pt) | 2017-06-26 |
| CN104955493A (zh) | 2015-09-30 |
| JP2016510315A (ja) | 2016-04-07 |
| EP2745852A1 (en) | 2014-06-25 |
| JP6518591B2 (ja) | 2019-05-22 |
| AU2013366544A1 (en) | 2015-07-09 |
| BR112015014926B1 (pt) | 2020-01-28 |
| WO2014096354A1 (en) | 2014-06-26 |
| US20160082145A1 (en) | 2016-03-24 |
| ES2627053T3 (es) | 2017-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20220068T1 (hr) | Staphylococcus aureus leukocidini, terapijski pripravci, i njihova uporaba | |
| NZ592509A (en) | HLA-A*1101-restricted WTI peptide and pharmaceutical composition comprising the same | |
| CY1119140T1 (el) | Συνθεσεις αντικωδικευσης και μεθοδοι κατασκευης και χρησης τους | |
| RS54707B1 (en) | TREATMENT OF CROWN LAKVINIMOD DISEASE | |
| BR112018004536A2 (pt) | peptídeos de endereçamento à cartilagem | |
| RS54551B1 (en) | NEUROPROTECTION IN DEMYELINING DISEASES | |
| RU2014103288A (ru) | Слитые полипептиды релаксина и их применение | |
| IL207468A (en) | HCV inhibitors and their use in the preparation of medicines for the treatment of HCV infections | |
| EA200701913A1 (ru) | Лечение статином, омега-3 жирными кислотами и их комбинированным продуктом | |
| CL2012002031A1 (es) | Composición farmacéutica que contiene al menos un compuesto fgf-21 (factor de crecimiento de fibroblastos 21) y al menos un agonista del glp-1r (receptor del péptido 1 similar al glucagón); y su uso para preparara un medicamento para el tratamiento de al menos un síndrome metabólico y/o aterosclerosis en un paciente. | |
| HRP20190982T1 (hr) | Peptidi i njihova uporaba | |
| CL2007000161A1 (es) | Compuestos derivados de 2,4-dioxoimidazolidina sustituida, inhibidores de proteinas cinasas; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer. | |
| EP2753348A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CANCER WITH AN INTERFERON ALPHA CONJUGATE | |
| HRP20150664T1 (hr) | Antikancerogeni fuzijski protein | |
| BR112013004436A2 (pt) | composições e usos de materiais com atividade microbicida alta e toxicidade baixa | |
| HRP20160646T1 (hr) | Poboljšano liječenje multiplog mijeloma | |
| ATE413865T1 (de) | Zusammensetzungen mit alphahydroxy-säureester zur wirkstofffreisetzung und anwendungsverfahren dafür | |
| WO2012177653A3 (en) | Targeting the neuromuscular junction for treatment | |
| PE20110677A1 (es) | Polimorfo b de la n-(2-aminofenil)-4-[n-(piridin-3-il) metoxicarbonilamino-metil]benzamida (ms-275) | |
| PE20090387A1 (es) | Formulacion de pasireotida | |
| HRP20140570T1 (hr) | Pripravci i postupci za tretiranje friedreichove ataksije pomoä†u interferon game | |
| HRP20170880T1 (hr) | Sastavi za brtvljenje | |
| FR2943253B1 (fr) | Composition contenant l'association de madecassoside, d'une arginine et de polysorbate | |
| FR2963237B1 (fr) | Nouvelle composition pharmaceutique utile pour prevenir ou traiter l'hypotension arterielle peroperatoire chez l'etre humain | |
| JP2016510315A5 (hr) |